myopia
1
%
Prevalence of myopia worldwide until 2050*
high myopia
1
%
With risks of eye diseases until 2050*
lower risk
1
%
by reducing the progression of 1 dioptre*
Putting myopia control into practice.
We as Eye Care Professionals have all become aware of the so called epidemic of myopia extending across the world. Not just in the Far East but also on our doorstep. In Europe and the USA there is a doubling of the incidence of myopia in children over the past decades. Many of these children becoming highly myopic and at risk of sight threatening complications associated with every increased Dioptre of Myopia.
Can we as Eye Care Specialists slow or stop Myopia? The evidence suggests the answer is ‘Yes’!
MyoCalc - THE MYOPIA CALCULATORS
Available for free on the public website Myopia.Care or with additional features in the MyoCalc Pro version—exclusively for Myopia.Care members.
MyoCalc – the myopia calculators with the Myopia predictior MyAppia, the Eye Length graph and Annual Eye Growth graphs are integrated into our Myopia.Care website.
MyoCalc—the myopia calculator featuring the MyAppia myopia prediction tool, the axial length chart, and the annual eye growth charts—is integrated into our Myopia.Care website. Analyze, assess, and advise. All in one.
’Myopia.Care’ offers a scientific approach to support a clinical pathway for children and young adults at risk of myopia or myopia progression, their parents and eye care professionals.
Designed to limit the progression of myopia and its associated potential for sight threatening complications later in life.
The web-based utility ‘Myopia.Care’ uses predictive myopia risk calculators and a guideline of recommended strategies based on over 50 published, peer reviewed papers and journals.
The website has a PUBLIC facing presence linked to a PROFESSIONAL version restricted to Eye Care Professionals.
It all starts with the PUBLIC version that collects specific data to calculate a predictive ‘Myopia.Care Index’.
PUBLIC pages provides access to various features that are essential for easily counseling children with myopia. These include MyAppia’s myopia prognosis curve, the eye growth curve and the annual eye growth chart for assessing treatment success. These tools enable comprehensive counseling and help you better understand the progression of myopia in children.
Data will not be stored. Measurements are saved in the patient file, enabling detailed documentation and follow-up in the MyoCalc Pro Version.
Public facing
’Myopia.Care’ offers a scientific approach to support a clinical pathway for children and young adults at risk of myopia or myopia progression, their parents and eye care professionals.
Designed to limit the progression of myopia and its associated potential for sight threatening complications later in life.
The web-based utility ‘Myopia.Care’ uses predictive myopia risk calculators and a guideline of recommended strategies based on over 50 published, peer reviewed papers and journals.
The website has a PUBLIC facing presence linked to a PROFESSIONAL version restricted to Eye Care Professionals.
It all starts with the PUBLIC version that collects specific data to calculate a predictive ‘Myopia.Care Index’.
PUBLIC pages provides access to various features that are essential for easily counseling children with myopia. These include MyAppia’s myopia prognosis curve, the eye growth curve and the annual eye growth chart for assessing treatment success. These tools enable comprehensive counseling and help you better understand the progression of myopia in children.
Data will not be stored. Measurements are saved in the patient file, enabling detailed documentation and follow-up in the MyoCalc Pro Version.
Public facing
Specialist facing
Developed by Eye Care Professionals for Eye Care Professionals.
The MyoCalc Pro version provides professionals with a tool that is backed by evidence to simplify communication and analysis in myopia management. It uses three special tools to show how myopia and eye length growth progress and compare them with treatment options.
The eye care professional can create a personalised treatment plan for each patient, check how well the current treatment is working, and show the results visually. The main difference to the public version is that the patient’s values are saved. This means that future measurements can be added quickly.
Parents also receive a detailed myopia report. This report contains information about the company and myopia. You can print the report and share the graphs digitally via a QR code. This makes it easy for eye care professionals to educate patients and monitor eye development over time.
Developed by Eye Care Professionals for Eye Care Professionals.
The MyoCalc Pro version provides professionals with a tool that is backed by evidence to simplify communication and analysis in myopia management. It uses three special tools to show how myopia and eye length growth progress and compare them with treatment options.
The eye care professional can create a personalised treatment plan for each patient, check how well the current treatment is working, and show the results visually. The main difference to the public version is that the patient’s values are saved. This means that future measurements can be added quickly.
Parents also receive a detailed myopia report. This report contains information about the company and myopia. You can print the report and share the graphs digitally via a QR code. This makes it easy for eye care professionals to educate patients and monitor eye development over time.
Specialist facing
’Myopia.Care’ is the collation of years of practical experience and constant review of published data from Scientific Journals.
’Myopia.Care’ was born out of the clinical need to react to the explosion of myopia in developed communities around the world.
The prevalence of myopia carries with it an exponential risk of sight threatening eye conditions. There is an overwhelming body of scientific evidence that suggests effective methods exist to reduce the pathogenesis of Myopic Eye Disease. Yet the majority of eye care professions fail to act appropriately due to the absence of a coherent message and availability of practical tools to provide a solution.
’Myopia.Care’ offers a scientific predictive calculators to target those at risk and assess treatment success to control myopic progression more effectively.
Offering guidance to the public, patient and professionals alike, drawing on constant review of scientific reports and peer review of best practice with products and tools to support myopia control.
’Myopia.Care’ offers an holistic and generic approach to the patient to limit the damage from progressive high myopia.
’Myopia.Care’ is an innovative service to deliver Myopia Control as a ‘ONE STOP SHOP’ for parents, children, professionals and manufacturers alike.
’Myopia.Care’ offers a scientific predictive calculators to target those at risk and assess treatment success to control myopic progression more effectively.
Offering guidance to the public, patient and professionals alike, drawing on constant review of scientific reports and peer review of best practice with products and tools to support myopia control.
’Myopia.Care’ offers an holistic and generic approach to the patient to limit the damage from progressive high myopia.
’Myopia.Care’ is an innovative service to deliver Myopia Control as a ‘ONE STOP SHOP’ for parents, children, professionals and manufacturers alike.
*References:
- WHO / BHVI 2015; The impact of Myopia and High Myopia: https://www.who.int/blindness/causes/MyopiaReportforWeb.pdf
- Bullimore, Mark A. MCOptom, PhD, FAAO1*; Brennan, Noel A. MScOptom, PhD, FAAO2 Myopia Control, Optometry and Vision Science: June 2019 – Volume 96 – Issue 6 – p 463-465 doi: 10.1097/OPX.0000000000001367